We are thrilled to announce that Sorriso has successfully completed enrollment in our Phase 1b clinical trial of patients with ulcerative colitis, marking a significant step forward in the development of SOR102. https://lnkd.in/gSKXMCnJ
Sorriso Pharmaceuticals
生物技术研究
San Diego，CA 474 位关注者
Harnessing the power of oral biologic therapies for patients with chronic illness
关于我们
Sorriso’s mission is to harness the power of oral biologic therapies that can be delivered directly to the site of disease, improving efficacy, safety and convenience for patients suffering from chronic illnesses.
- 网站
-
www.sorrisopharma.com
Sorriso Pharmaceuticals的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- San Diego，CA
- 类型
- 私人持股
- 创立
- 2020
地点
Sorriso Pharmaceuticals员工
动态
-
The Sorriso team had a blast joining the Crohn's & Colitis Foundation at Take Steps in San Diego this past weekend. Take Steps is the Foundation's largest nationwide fundraising campaign, to raise awareness and funds to accelerate the progress of breakthrough inflammatory bowel disease (IBD) research and to support critical patient programs. If you would like to donate to our team fundraising you can do so at https://lnkd.in/e7v3xVvV
-
-
So proud to contribute to this next generation approach to IBD treatment!
Sorriso Pharmaceuticals Announces First Patients Dosed in Phase 1b Clinical Trial for Patients with Ulcerative Colitis
einpresswire.com
-
Sorriso is excited to announce we have dosed the first patients in our Phase 1b clinical trial for patients with ulcerative colitis. https://lnkd.in/gjbPhTbc